A Study of Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies
Completed
Pharmacia and Upjohn
Phase 2
1969-12-31
The purpose of this study is to see if it is safe and effective to give delavirdine mesylate
(Rescriptor) plus two nucleoside reverse transcriptase inhibitors (NRTIs) to HIV-infected
children and babies. This study also examines how the body processes Rescriptor when taken
with 2 NRTIs.
Safety and Effectiveness of Giving Combinations of Three or Four Anti-HIV Drugs to HIV-Infected Patients
Completed
Pharmacia and Upjohn
N/A
1969-12-31
The purpose of this study is to see if it is safe and effective to give combinations of three
or four anti-HIV drugs to HIV-infected patients. The drugs used in this study are delavirdine
(DLV), nelfinavir (NLF), didanosine (ddI), and stavudine (d4T).
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
Completed
Pharmacia and Upjohn
N/A
1969-12-31
The purpose of this study is to compare the safety and effectiveness of giving HIV-infected
patients delavirdine (DLV) plus zidovudine (ZDV) plus 2 doses of indinavir (IDV) or ZDV plus
IDV plus lamivudine (3TC). This study also examines how the body processes DLV when it is
given in combination with other drugs.
A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected Patients
Completed
Pharmacia and Upjohn
N/A
1969-12-31
The purpose of this study is to see if it is safe and effective to give delavirdine (DLV) in
combination with two or three other drugs to HIV-infected patients. The drugs to be used in
combination with DLV are zidovudine (ZDV), indinavir (IDV), and lamivudine (3TC).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
